# The STOP-MED CTRCD Trial

Study · id `cardio:ct-nct06183437` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06183437](<https://clinicaltrials.gov/study/NCT06183437>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06183437

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 335 participants.

## Technical summary

Registry record NCT06183437. Randomized; no masking; primary purpose treatment. Start 2024-03-04 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 335 participants (planned count; ClinicalTrials.gov record NCT06183437, source copy `cardio:ctgov-nct06183437-2026-07-07`, retrieved 2026-10-26)
- Started: 2024-03-04 (actual) (ClinicalTrials.gov record NCT06183437, source copy `cardio:ctgov-nct06183437-2026-07-07`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT06183437, source copy `cardio:ctgov-nct06183437-2026-07-07`, retrieved 2026-10-26)
- Completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT06183437, source copy `cardio:ctgov-nct06183437-2026-07-07`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; Poland; Spain; United Kingdom (ClinicalTrials.gov record NCT06183437, source copy `cardio:ctgov-nct06183437-2026-07-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06183437-2026-07-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: The STOP-MED CTRCD Trial
- Acronym: STOP-MED CTRCD
- Condition: Heart Failure
- Condition: Cardiotoxicity
- Condition: Cardiac Toxicity
- Condition: Antineoplastics Toxicity
- Condition: Cancer
- Intervention (Other): Stopping Heart Failure Medication(s)
- Lead sponsor: Dinesh Thavendiranathan
- Lead sponsor class: OTHER
- Collaborator: Unity Health Toronto
- Collaborator class: OTHER
- Collaborator: Hamilton Health Sciences Corporation
- Collaborator class: OTHER
- Collaborator: St. Boniface Hospital
- Collaborator class: OTHER
- Collaborator: Ottawa Heart Institute Research Corporation
- Collaborator class: OTHER
- Collaborator: University College London Hospitals
- Collaborator class: OTHER
- Collaborator: Brigham and Women's Hospital
- Collaborator class: OTHER
- Collaborator: Baker Heart and Diabetes Institute
- Collaborator class: OTHER
- Collaborator: University of California, Los Angeles
- Collaborator class: OTHER
- Collaborator: Alberta Health services
- Collaborator class: OTHER
- Collaborator: Hospital Universitario La Paz
- Collaborator class: OTHER
- Collaborator: Liverpool Heart and Chest Hospital NHS Foundation Trust
- Collaborator class: OTHER
- Collaborator: Guy's and St Thomas' NHS Foundation Trust
- Collaborator class: OTHER
- Collaborator: Maria Sklodowska-Curie National Research Institute of Oncology
- Collaborator class: OTHER
- Collaborator: Memorial Sloan Kettering Cancer Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Unity Health Toronto (`cardio:org-unity-health-toronto`)
- Registry lists this organization as a collaborator: Hamilton Health Sciences Corporation (`cardio:org-hamilton-health-sciences-corporation`)
- Registry lists this organization as a collaborator: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)
- Registry lists this organization as a collaborator: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)
- Registry lists this organization as a collaborator: Baker Heart and Diabetes Institute (`cardio:org-baker-heart-and-diabetes-institute`)
- Registry lists this organization as a collaborator: University of California, Los Angeles (`cardio:org-university-of-california-los-angeles`)
- Registry lists this organization as a collaborator: Alberta Health services (`cardio:org-alberta-health-services`)
- Registry lists this organization as a collaborator: Hospital Universitario La Paz (`cardio:org-hospital-universitario-la-paz`)
- Registry lists this organization as a collaborator: Liverpool Heart and Chest Hospital NHS Foundation Trust (`cardio:org-liverpool-heart-and-chest-hospital-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: Guy's and St Thomas' NHS Foundation Trust (`cardio:org-guy-s-and-st-thomas-nhs-foundation-trust`)

## Provenance

Content hash: 54cb90337b8cf86a8ef210123e231e4ee5f36052ba206adbfa7b5f576b0b88b1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
